To clarify the effect of Mirabilitum in formularization, change of prolyl endopeptidase inhibitory activity and of constituents using the preparation method of a Kampo formula Tokaku-joki-to ( , Persia and Rhubarb combination) was examined by the liquid chromatography-mass spectroscopy (LC-MS) method. Mirabilitum under boiling condition caused qualitative and quantitative change of the constituents through hydrolysis which caused a change of its activity. This was considered to be the main reason the classical Chinese medical book "Shang han lun ( )" specified that Mirabilitum should be added at a later stage of decoction.
In the People's Republic of China and Japan, there are two therapies to treat diseases: Chinese medicine (Kampo medicine in Japan) and modern Western medicine. The former is characterized by the concept of the specific conditions "sho ( , syndrome differentiation)" and the use of a formula "hou-zai ( )", corresponding to the "sho" of each patient. The formula is prepared from crude drugs according to the "sho", and some quantitative and/or qualitative change of constituents during preparation of a formula is believed to make the individual treatment feasible. Thus, a chemical examination on the change is necessary for understanding Chinese (Kampo) medicine.
In the course of our search for prolyl endopeptidase (PEP, EC 3.4.21.26) inhibitors from traditional Chinese (Kampo) medicines, 1, 2) we found that Tokaku-joki-to ( , Persia and Rhubarb combination) has the PEP inhibitory activity (inhibition rate of 100 mg/ml, 99.6%).
3) Tokaku-joki-to is an oriental blood-quickening and stasis-transforming prescription, which consists of Persicae Semen ( ), Rhei Rhizoma ( ), Cinnamomi Cortex ( ), Glycyrrhizae Radix ( ) and Mirabilitum ( ) and is used clinically in the People's Republic of China and Japan for the treatment of amenorrhea, climacteric syndrome, emotional imbalance and so on. 4, 5) Our chemical examination of the PEP inhibitory constituents resulted in the identification of twentyseven constituents including thirteen active ones, 3) which had been reported to be contained in Rhei Rhizoma and/or Cinnamomi Cortex. We thus examined the PEP inhibitory activities of the crude drugs which compose Tokaku-joki-to. In a classical Chinese medical book "Shang han lun ( )", on the other hand, the decoction method of Tokaku-joki-to has been described as follows ( Fig. 1) : place Persicae Semen (5.0 g), Rhei Rhizoma (3.0 g), Cinnamomi Cortex (4.0 g) and Glycyrrhizae Radix (1.5 g) in 7 l of water, boil them down into 2.5 l, remove the sediment, add the Mirabilitum and simmer the mixture until dissolved. 4) This description seemed to indicate the qualitative and/or quantitative change of constituents. Thus, we next examined the change using the liquid chromatography-mass spectroscopy (LC-MS) method with the twenty-seven compounds (1-27, Fig. 2 ) isolated from Tokaku-joki-to as standards.
Experimental
Preparation of Extracts of Crude Drugs and Formulas Rhei Rhizoma (Rheum palmatum LINNE, Sichuan Province in China), Cinnamomi Cortex (Cinnamomum cassia BLUME, Guangdong Province in China), Persicae Semen (Prunus persica BATSCH, Shanxi Province in China), Glycyrrhizae Radix (Glycyrrhiza uralensis FISHER, Hebei Province in China) and Natrium Sulfuricum (Na 2 SO 4 ) were supplied by Kotaro Kampo Pharmaceutical Co., Ltd., Osaka, Japan, while Magnesium Sulfuricum (MgSO 4 ) was purchased from Nacalai Tesque Co. (Kyoto, Japan).
Each crude drug was extracted 3 times with 1 l of boiling water for 1 h. The extracts were combined, concentrated in vacuo and then freeze-dried. The yield of each extract from R. palmatum, C. cassia, G. uralensis and P. persica was 13.4, 4.5, 15.5 and 11.2%, respectively (Table 1) .
Formula A0 was prepared by the method described in a classical Chinese medical book "Shang han lun ( )" (Fig. 1) 4) with a yield of 21.6%. Formula A1 was prepared by decocting the mixture of Rhei Rhizoma, Cinnamomi Cortex, Persicae Semen and Glycyrrhizae Radix with distilled water (700 ml) for 1 h, followed by filtration of the mixture, concentration of the filtrate to 250 ml and lyophilization; yield, 16.0%. Formulas A2 and A3 were prepared by decocting the crude drugs with Na 2 SO 4 (A2) or MgSO 4 (A3) with the same procedure as formula A1 with a yield of 20.0% (A2) or 17.4% (A3). Formula A4 was prepared by boiling formula A1 with Na 2 SO 4 for 30 min, followed by lyophilization.
Mixtures B1-B4 were prepared by grounding the extracts of the crude drugs corresponding to the above formulas A1-A4; ratio of each extract (Table 1) was calculated based on the yield from each crude drug. Extracts C1 and C2 were prepared by boiling the extracts from Rhei Rhizoma and Cinnamomi Cortex with Na 2 SO 4 for 1 h.
PEP Inhibitory Activity PEP (Flavobacterium meningosepticum origin) was purchased from Seikagaku Corporation (Tokyo, Japan) and a substrate, Z-Gly-Pro-pNA, from Bachem Fine Chemical Co. (Switzerland). PEP inhibitory activities were measured by the method of Yoshimoto et al. 6) as described in our previous papers. were isolated from EtOAc-soluble and BuOH-soluble fractions of a commercial Tokaku-joki-to by a combination of column chromatography and preparative thin layer chromatography (TLC), as described.
1-3)

LC-MS Analysis
3)
Each sample was dissolved in HPLC-grade H 2 O (10 mg/ml) and filtered using a HPLC-Disk 13 filter (Kanto Chemical Co. Inc, Japan), and 10 ml of the filtrate was directly subjected to LC-MS analysis. The analysis was performed on a JEOL JMS-700T mass spectrometer (Tokyo), equipped with a HP1100 liquid chromatograph (Hewlett-Packard, Germany), with an atmospheric pressure chemical ionization (APCI) mode: temperature, 400°C; ion injection time, 0.1 s; column, Supelco discovery C 18 (4.6ϫ250 mm; U.S.A.); mobile phase, 10 mM AcOH-CH 3 CN (linear gradient, 95 : 5→35 : 65 for 60 min); flow rate, 0.5 ml/min; UV, 220 nm.
Results and Discussion
In the previous paper, 3) we determined the PEP inhibitory constituents in a commercial Tokaku-joki-to to be 2, 7-10, 14-16, 18, 19 and 24-26, which had been reported as constituents of Rhei Rhizoma (1-19, 25-27) and Cinnamomi Cortex (1, 25-27). We thus examined the PEP inhibitory activity of each crude drug in order to learn which one contributes to the activity of Tokaku-joki-to. As can be seen in Table 2 , Rhei Rhizoma and Cinnamomi Cortex showed strong inhibitory activity (IC 50 , 0.73 and 2.72 mg/ml, respectively), while Persicae Semen, Glycyrrhizae Radix and Natrium Sulfuricum showed no activity. The inhibitory activity of the former two were stronger than that of the formula Tokaku-joki-to (A2; IC 50 , 12.9 mg/ml), suggesting that combination of the crude drugs could affect the PEP inhibitory activity. In addition, Magnesium Sulfuricum (MgSO 4 ), which was at one time used as Mirabilitum in Japan, 7) showed the same weak PEP inhibitory activity as Natrium Sulfuricum (Na 2 SO 4 ) which is used these days.
The commercial Tokaku-joki-to, which we used in the previous examination, 3) was prepared by the same method as formula A2. However, as described above, the method differed from the original one described in the classical Chinese medical book "Shang han lun ( )" in the time of adding Mirabilitum: in formula A2 Mirabilitum was mixed from the first and boiled; in formula A0 it was mixed after the decoction of the other four crude drugs. Thus, we focused on the effect of Mirabilitum on the change of PEP inhibitory activity and the constituents.
Formula A1 without Mirabilitum showed stronger inhibitory activity than the original formula A0 with Mirabilitum (Na 2 SO 4 ), and formulas A2 and A3 (containing Na 2 SO 4 and MgSO 4 , respectively, as Mirabilitum) showed significant decrease of the inhibitory activity (Table 2) . These results indicated that the presence of Mirabilitum (Na 2 SO 4 or MgSO 4 ) decreased the PEP inhibitory activity, which was also observed in the case of mixtures of extracts (B1-B3). In these experiments, the PEP inhibitory activities of formulas A2 and A3 and of mixtures B2 and B3 were almost the same, indicating that there should be no difference between Natrium Sulfuricum (Na 2 SO 4 ) and Magnesium Sulfuricum (MgSO 4 ). Thus, we used Natrium Sulfuricum (Na 2 SO 4 ) as Mirabilitum in the subsequent experiments.
Then, we examined the change of the constituents with HPLC using both UV and APCI-MS detections. The HPLC profile of a mixture of standard compounds with UV detection showed clear separation of almost all of them (Fig. 3) . Compounds 11 and 25, compounds 12, 21 and 26 and compounds 1 and 15, which could not be separated by UV detec- tion, were also separated in the mass chromatograms of the quasimolecular ions due to their different molecular weights. The HPLC profiles of formulas A0-A2 with UV detection clearly showed the decrease of the amount of constituents in the order A1ϾA0ϾA2 (Fig. 4) . In the mass chromatograms of the quasimolecular ions for compounds 1-27 in formula A1 (without Na 2 SO 4 ), compounds 1, 7, 11-13, 18, 21-23, 25 and 27 were detected, but those of the formula A2 (with Na 2 SO 4 ) indicated their quantity was decreased; compounds 13, 22, 25 and 27 could not be detected (Table 3) . Similar reduction of the constituents was also observed in the original formula A0 when Na 2 SO 4 was added later. Thus, Natrium Sulfuricum (Na 2 SO 4 ) should bring a quantitative change of the constituents, which would induce the weakening of the PEP inhibitory activity. The difference between formulas A1 and A2/A3 was larger than that between mixtures B1 and B2/B3, and formula A1 showed slightly stronger activity than the original formula A0. The large difference between these formulas and mixtures was the heating period with Mirabilitum: formula A1 and mixture B1 were not heated with Mirabilitum; original formula A0 and mixtures B2 and B3 were slightly heated to dissolve Mirabilitum; and formulas A2 and A3 were decocted with Mirabilitum. Thus, the heating process with Mirabilitum seemed to contribute to the reduction in PEP inhibitory activity. In order to verify this, we boiled formula A1 with Na 2 SO 4 for 30 min to get formula A4, while mixture B2 containing Na 2 SO 4 was boiled for 30 min to give mixture B4. The heating with Na 2 SO 4 decreased the PEP inhibitory activity (Table 2) , and the HPLC profile with UV detection showed the decrease in the amounts of the constituents (Fig.  5) . In the mass chromatograms of the quasimolecular ions of compounds 1-27 of mixture B2, compounds 3, 7, 11, 12, 20 and 27 were detected ( Table 3 ). The mass chromatograms of mixture B4 also showed the decrease of compounds 3, 11, 12, 20 and 27, but interestingly, the amounts of compounds 7 and 21 were increased and compound 1 was newly detected. From these data, together with consideration of their structures, gallates and/or glycosides such as 8, 9, 22 and 23 were hydrolyzed to give compounds 7 and 21, while 1 may be derived from cinnamic acid esters such as 15 and 16, i.e., Mirabilitum (Na 2 SO 4 ) in the formulas, under the heating condition, brought about a qualitative and quantitative change in the constituents.
This was further confirmed by examining the effect of Mirabilitum (Na 2 SO 4 ) under boiling condition on the extracts from Rhei Rhizoma and Cinnamomi Cortex. The PEP inhibitory activity of the extracts C1 and C2, prepared by boiling the extracts from Rhei Rhizoma and Cinnamomi Cortex with Na 2 SO 4 , was significantly decreased (Table 2 ). In addition, the HPLC chromatograms of the extracts C1 and C2 with UV detection showed the quantitative and qualitative decrease of the constituents compared with those of Rhei Rhizoma and Cinnamomi Cortex, respectively (Fig. 6) . In accordance with this, the mass chromatograms of the quasimol- Formula A0 consisted of Persicae Semen, Cinnamomi Cortex, Glycyrrhizae Radix, Rhei Rhizoma, Mirabilitum (Na 2 SO 4 ) and was prepared by the method described in the classical Chinese medical book "Shang han lun". Formula A1 was prepared by decocting the crude drugs other than Mirabilitum (Na 2 SO 4 ). Formula A2 was prepared by decocting the crude drugs including Mirabilitum (Na 2 SO 4 ).
Fig. 5. HPLC Profiles of the Water Solutions of Mixtures B2 and B4
Mixtures B2 and B4 were prepared by grounding the extracts of the crude drugs corresponding to formulas A2 and A4, respectively. ecular ions of compounds 2, 4, 6-9, 11-14, 17-19 and 25-27 indicated the decrease of their quantity in the extract C1, but that of gallic acid (3) increased in extract C1 (Table  3) . A similar tendency was also observed in the mass chromatograms of Cinnamomi Cortex and the extract C2. From these data, it was concluded that Mirabilitum (Na 2 SO 4 ) under boiling condition caused the quantitative and qualitative change of constituents through hydrolysis to decrease the PEP inhibitory activity.
Conclusion
In this paper, we have reported that Mirabilitum under boiling condition changed the constituents qualitatively and quantitatively through hydrolysis and caused a change in their activity. Thus, to avoid hydrolysis by Mirabilitum, the classical Chinese medical book "Shang han lun" specified that Mirabilitum should be added at a later stage of decoction. Interestingly, the same specification was indicated on other formulas containing Mirabilitum, such as Choi-joki-to ( , Rhubarb and Mirabilitum Combination), Daiobotanpi-to ( , Rhubarb and Moutan Combination) and Saiko-ka-bosho-to ( , Bupleurum and Mirabilitum Combination), 8) suggesting that the same phenomenon occurred.
